Article info
Correspondence
Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
- Correspondence to Dr Aran Tajika, Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto, Kyoto, Japan; aran.tajika28{at}gmail.com
Citation
Blinding successfulness in antipsychotic trials of acute treatment for schizophrenia: a systematic review
Publication history
- Received March 1, 2023
- Accepted March 12, 2023
- First published April 21, 2023.
Online issue publication
February 15, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.